Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
AVEO PHARMACEUTICALS, INC. (AVEO) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/19/2023 4 BATE KENNETH (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 375 shares @ $15, valued at $5.6k
Disposed/sold 1,250 options to buy @ $25.9, valued at $32.4k
Disposed/sold 1,250 options to buy @ $15.7, valued at $19.6k
Disposed/sold 2,515 options to buy @ $16.1, valued at $40.5k
Disposed/sold 2,000 options to buy @ $20, valued at $40k
Disposed/sold 6,402 options to buy @ $9.2, valued at $58.9k
Disposed/sold 7,785 options to buy @ $7, valued at $54.5k
Disposed/sold 4,000 options to buy @ $22.7, valued at $90.8k
Disposed/sold 4,000 options to buy @ $7.6, valued at $30.4k
Disposed/sold 4,000 options to buy @ $7.52, valued at $30.1k
Disposed/sold 12,500 options to buy @ $7.27, valued at $90.9k
01/19/2023 4 EVNIN ANTHONY B (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 41,841 shares @ $15, valued at $627.6k
Disposed/sold 1,250 options to buy @ $25.9, valued at $32.4k
Disposed/sold 1,250 options to buy @ $15.7, valued at $19.6k
Disposed/sold 2,515 options to buy @ $16.1, valued at $40.5k
Disposed/sold 2,000 options to buy @ $20, valued at $40k
Disposed/sold 6,402 options to buy @ $9.2, valued at $58.9k
Disposed/sold 7,785 options to buy @ $7, valued at $54.5k
Disposed/sold 4,000 options to buy @ $22.7, valued at $90.8k
Disposed/sold 4,000 options to buy @ $7.6, valued at $30.4k
Disposed/sold 4,000 options to buy @ $7.52, valued at $30.1k
Disposed/sold 12,500 options to buy @ $7.27, valued at $90.9k
01/19/2023 4 Ledell Jebediah (COO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 170,000 options to buy @ $5.92, valued at $1M
Disposed/sold 27,702 options to buy @ $3.67, valued at $101.7k
01/19/2023 4 Ferraresso Michael (Chief Commercial Officer) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 16,345 shares @ $15, valued at $245.2k
Disposed/sold 20,000 options to buy @ $28.3, valued at $566k
Disposed/sold 3,749 options to buy @ $30.8, valued at $115.5k
Disposed/sold 35,064 options to buy @ $6.2, valued at $217.4k
Disposed/sold 42,499 options to buy @ $5.6, valued at $238k
Disposed/sold 100,000 options to buy @ $9.12, valued at $912k
Disposed/sold 220,000 options to buy @ $3.67, valued at $807.4k
01/19/2023 4 Epperly Corinne (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 10,000 options to buy @ $6.31, valued at $63.1k
Disposed/sold 15,000 options to buy @ $6.46, valued at $96.9k
Disposed/sold 22,500 options to buy @ $4.27, valued at $96.1k
01/19/2023 4 Cullen Kevin Joseph (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 25,000 options to buy @ $6.3, valued at $157.5k
Disposed/sold 22,500 options to buy @ $4.27, valued at $96.1k
01/19/2023 4 Spring Scarlett (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 10,000 options to buy @ $6.6, valued at $66k
Disposed/sold 4,000 options to buy @ $7.52, valued at $30.1k
Disposed/sold 12,500 options to buy @ $7.27, valued at $90.9k
Disposed/sold 22,500 options to buy @ $4.27, valued at $96.1k
01/19/2023 4 Mayes, Gregory T. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 10,000 options to buy @ $6.1, valued at $61k
Disposed/sold 4,000 options to buy @ $7.52, valued at $30.1k
Disposed/sold 12,500 options to buy @ $7.27, valued at $90.9k
Disposed/sold 22,500 options to buy @ $4.27, valued at $96.1k
01/19/2023 4 BAILEY MICHAEL P (President & CEO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 333,167 shares @ $15, valued at $5M
Disposed/sold 3,249 options to buy @ $77.2, valued at $250.8k
Disposed/sold 11,999 options to buy @ $25.1, valued at $301.2k
Disposed/sold 7,499 options to buy @ $17.7, valued at $132.7k
Disposed/sold 90,000 options to buy @ $8.4, valued at $756k
Disposed/sold 46,000 options to buy @ $10.8, valued at $496.8k
Disposed/sold 75,366 options to buy @ $6, valued at $452.2k
Disposed/sold 99,999 options to buy @ $30.8, valued at $3.1M
Disposed/sold 16,750 options to buy @ $15.7, valued at $263k
Disposed/sold 93,500 options to buy @ $6.2, valued at $579.7k
Disposed/sold 35,302 options to buy @ $5.6, valued at $197.7k
01/19/2023 4 Lucera Erick (CFO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Disposed/sold 50,000 options to buy @ $6.7, valued at $335k
Disposed/sold 100,000 options to buy @ $9.12, valued at $912k
Disposed/sold 218,800 options to buy @ $3.67, valued at $803k
12/22/2022 4 BAILEY MICHAEL P (President & CEO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Exercised 26,499 options to buy @ $6.2, valued at $164.3k
Exercised 85,722 options to buy @ $5.6, valued at $480k
Exercised 164,525 options to buy @ $3.67, valued at $603.8k
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 BATE KENNETH (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 22,500 options to buy @ $4.27, valued at $96.1k
06/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Mayes, Gregory T. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 22,500 options to buy @ $4.27, valued at $96.1k
06/08/2022 4 Spring Scarlett (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 22,500 options to buy @ $4.27, valued at $96.1k
06/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2022 4 Ferraresso Michael (Chief Commercial Officer) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 220,000 options to buy @ $3.67, valued at $807.4k
02/17/2022 4 Lucera Erick (CFO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 218,800 options to buy @ $3.67, valued at $803k
02/17/2022 4 BAILEY MICHAEL P (President & CEO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 789,717 options to buy @ $3.67, valued at $2.9M
02/17/2022 4 Ledell Jebediah (COO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 27,702 options to buy @ $3.67, valued at $101.7k
12/03/2021 4 Ledell Jebediah (COO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 170,000 options to buy @ $5.92, valued at $1M
09/03/2021 4 BAILEY MICHAEL P (President & CEO) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Bought 15,000 shares @ $6.48, valued at $97.2k
08/11/2021 4 Ferraresso Michael (Chief Commercial Officer) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Bought 2,608 shares @ $5.75, valued at $15k
06/09/2021 4 Spring Scarlett (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 12,500 options to buy @ $7.27, valued at $90.9k
06/09/2021 4 Mayes, Gregory T. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.
Txns: Granted 12,500 options to buy @ $7.27, valued at $90.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy